The accurate identification of bacterial pathogens and the timely determination of their antimicrobial susceptibility are fundamental components of contemporary clinical microbiology. As bacterial infections continue to present complex diagnostic and therapeutic challenges, microbiology laboratories increasingly require analytical systems that can generate dependable results while reducing the time, labour, and procedural variability associated with conventional methods. Automated identification and antimicrobial susceptibility testing (AST) platforms have therefore become important tools for transforming microbiological observations into clinically useful information. Among these technologies, the VITEK 2 Automated Compact System represents an integrated laboratory platform designed to support the rapid characterization of bacterial isolates and the assessment of their responses to antimicrobial agents.
The VITEK 2 Compact system combines automated bacterial identification with antimicrobial susceptibility determination within a standardized workflow. Its operation is based on specialized identification and susceptibility cards containing miniaturized biochemical or antimicrobial test systems. Following inoculation with a standardized bacterial suspension, the cards are processed automatically, allowing multiple reactions to be monitored under controlled conditions. This approach introduces a high degree of procedural consistency and minimizes several manual operations traditionally associated with microbiological testing. The system consequently provides a structured pathway from an isolated bacterial colony to an interpretable identification and susceptibility profile.
A notable feature of the VITEK 2 Compact is its capacity to examine diverse bacterial characteristics through miniaturized biochemical reactions. The resulting reaction patterns are analyzed electronically and compared with established identification databases to facilitate organism-level characterization. In parallel, AST cards enable the system to evaluate bacterial growth in the presence of selected antimicrobial concentrations, producing susceptibility information that can assist in distinguishing susceptible, intermediate, and resistant phenotypes according to applicable interpretive criteria. The automation of these processes contributes to a more systematic approach to laboratory diagnostics.
Beyond its analytical functions, the VITEK 2 Compact incorporates features intended to improve workflow organization, data management, and result interpretation. Automated incubation, continuous monitoring, computerized analysis, and electronic reporting reduce dependence on repeated manual observations and create opportunities for more efficient laboratory operation. The system can also support the recognition of unusual susceptibility patterns, making automated AST an important component of antimicrobial stewardship and resistance surveillance.
VITEK 2 Compact combination of automation, standardized testing, computerized interpretation, and integrated identification and susceptibility analysis provides a distinctive framework for examining bacterial isolates and generating laboratory data relevant to clinical decision-making.
Clinical importance of rapid microbial identification and AST
The effective management of infectious diseases depends substantially on the ability of healthcare professionals to identify the causative microorganism and determine its antimicrobial response within an appropriate clinical timeframe. In many infections, empirical therapy is initiated before laboratory confirmation is available; however, continued reliance on empirical treatment may expose patients to inappropriate antimicrobial agents, delay effective therapy, and contribute to unnecessary antimicrobial pressure. The provision of precise microbial identification and reliable AST is an essential function of modern clinical microbiology. Laboratory-generated information enables physicians to move from broad empirical treatment toward targeted antimicrobial therapy based on the characteristics of the infecting organism.
Clinical microbiology laboratories occupy a strategic position in this process because they serve as diagnostic surveillance points for bacterial pathogens recovered from clinical specimens. Samples such as blood, urine, sputum, wound material, cerebrospinal fluid, and other relevant specimens may contain microorganisms responsible for infection, colonization, or contamination. Differentiating these possibilities requires dependable laboratory procedures and competent interpretation. Accurate organism identification provides the foundation for selecting appropriate antimicrobial agents, while AST supplies additional information concerning the likelihood that the identified organism will respond to particular drugs. Together, these processes transform a clinical specimen into actionable microbiological evidence.
The importance of this function has become increasingly pronounced with the expansion of antimicrobial resistance. Resistant bacterial populations can compromise commonly available therapeutic options and complicate the management of infections that were previously considered readily treatable. Clinical laboratories therefore contribute not only to individual patient management but also to the broader detection and monitoring of resistance patterns within healthcare environments. Systematic laboratory testing can reveal emerging resistance phenotypes, unusual susceptibility profiles, and shifts in the distribution of resistant organisms. Such information is valuable for infection prevention, antimicrobial stewardship, hospital surveillance, and epidemiological assessment.
For the individual patient, speed is particularly consequential. A delay between specimen collection, organism identification, susceptibility testing, and communication of results can prolong exposure to ineffective therapy or unnecessarily broad-spectrum treatment. Rapid laboratory reporting can support earlier therapeutic modification and potentially improve the precision of antimicrobial prescribing. The objective is not simply to obtain a result quickly, but to obtain a result that is analytically sound, clinically interpretable, and delivered within a timeframe that can influence patient care.
High-quality clinical microbiology services consequently require an appropriate balance of accuracy, reproducibility, efficiency, and throughput. Conventional microbiological approaches remain valuable, but many may involve sequential procedures, prolonged incubation, manual observations, and substantial technical intervention. Automated platforms have emerged partly in response to these operational demands. By integrating organism identification and AST into standardized analytical workflows, automated systems can reduce repetitive manual activities while facilitating consistent processing of multiple isolates.
The VITEK 2 Automated Compact System exemplifies this transition toward automated microbiological analysis. Its integration of identification and susceptibility testing provides a laboratory framework in which bacterial isolates can be processed systematically and results generated through computerized analytical procedures. The significance of such technology extends beyond convenience: it reflects the increasing need for clinical laboratories to produce reliable microbiological information at a pace compatible with contemporary clinical decision-making. In infectious disease management, timely laboratory evidence can therefore function as a critical bridge between diagnostic microbiology and individualized antimicrobial therapy.
Automation, colorimetric identification, and analytical capacity of the VITEK 2 compact system
The VITEK 2 Automated Compact System is designed as an integrated, automated platform for microbial identification and antimicrobial susceptibility testing. Its principal value lies in the incorporation of multiple analytical stages into a coordinated laboratory workflow, thereby reducing the dependence on extensive manual manipulation. Rather than treating bacterial identification and susceptibility assessment as entirely separate procedures, the system provides an automated environment in which both activities can be performed using dedicated cards and computerized analysis. This configuration is particularly relevant to laboratories seeking greater operational efficiency, standardized processing, and increased testing capacity.
A central characteristic of the system is its use of miniaturized biochemical reactions for microbial identification. Identification cards contain a series of substrates and biochemical test conditions that permit the assessment of metabolic characteristics expressed by the bacterial isolate. After preparation of an appropriate microbial suspension, the inoculated card is introduced into the instrument, where incubation and monitoring occur automatically. Changes associated with microbial metabolic activity generate measurable signals that form a biochemical profile. The resulting profile is analyzed by the system’s software and compared with reference information to establish the most probable identity of the organism.
Colorimetric detection constitutes an important component of this analytical process. Colorimetry involves the measurement and interpretation of changes in light absorption associated with chemical or biochemical reactions. In microbiological identification, metabolic activity can produce changes in reaction intensity or colour that are detected instrumentally rather than being assessed solely by visual inspection. The instrument consequently converts biochemical reactions into measurable analytical signals. This approach provides a standardized means of evaluating numerous reactions simultaneously and supports reproducible interpretation across processed isolates.
The underlying concept is related to spectrophotometric measurement, in which the interaction between light and a substance is quantified according to changes in transmitted or absorbed light. Although colorimetry and spectrophotometry are related analytical approaches, they should not be regarded as interchangeable concepts. Colorimetric systems commonly emphasize measurable colour development resulting from a reaction, whereas spectrophotometry provides quantitative measurement of light absorption across specified wavelengths. In the VITEK 2 system, optical detection is incorporated into an automated microbiological workflow to monitor reaction changes and generate data suitable for computerized identification.
The platform also incorporates dedicated AST cards for evaluating bacterial responses to antimicrobial agents. These tests enable bacterial growth behaviour to be assessed in relation to defined antimicrobial concentrations, producing susceptibility information that can subsequently be interpreted according to applicable laboratory standards and breakpoints. This is particularly important because antimicrobial susceptibility is not inferred solely from bacterial identity. Closely related organisms may exhibit different resistance mechanisms, while individual isolates of the same species can display markedly different susceptibility patterns. Automated AST therefore provides a complementary analytical dimension to organism identification.
Another defining characteristic of the VITEK 2 Compact is its capacity to support laboratories with different testing demands while maintaining a relatively compact physical configuration. Its automation can facilitate the processing of multiple isolates and reduce repetitive technical tasks, making the platform relevant to both laboratories with moderate workloads and facilities handling larger numbers of specimens. Computerized data acquisition and interpretation further support organized result management and reporting.
The combined use of automated processing, miniaturized biochemical reactions, optical detection, computerized interpretation, and susceptibility analysis gives the VITEK 2 Compact a distinctive role in contemporary bacteriological diagnostics. Rather than merely accelerating individual laboratory procedures, the system represents an integrated approach to converting microbial growth and biochemical behaviour into structured diagnostic information. Its analytical architecture therefore supports the broader objective of producing timely, standardized, and clinically useful identification and AST results within the routine workflow of the clinical microbiology laboratory.
Notable features of the VITEK 2 compact automated system
The VITEK 2 Compact Automated System incorporates a range of technological and analytical features intended to improve the identification of bacterial pathogens and the determination of their antimicrobial susceptibility. Its design combines an extensive microbial knowledge base, specialized identification and susceptibility cards, automated optical detection, computerized interpretation, and an integrated instrument configuration. These features allow the system to process microbiological information in a structured manner while reducing repetitive manual procedures.
The principal features of the VITEK 2 Compact system are as follows:
1. Comprehensive and updatable Microbial database
A major feature of the VITEK 2 Compact system is its comprehensive microbial knowledge base, which supports the computerized interpretation of biochemical and susceptibility data generated during testing. The database has been developed from a large body of reference information derived from microbial strains and their corresponding phenotypic characteristics. This extensive reference foundation enables the system to compare the reaction profile generated from an unknown bacterial isolate with established microbial profiles and subsequently assign an identification.
The database is also designed to accommodate updates, allowing the information used for microbial identification and susceptibility interpretation to evolve as additional knowledge becomes available. An expandable knowledge base is particularly important in clinical microbiology because bacterial taxonomy, resistance phenotypes, and susceptibility patterns are not static. Continuous refinement of reference information can therefore enhance the system’s capacity to accommodate diagnostically relevant organisms and phenotypic variations.
2. Extensive microbial knowledge base and phenotypic recognition
The knowledge base associated with the VITEK 2 system has been described as incorporating approximately 100,000 microbial strain references. Such a substantial reference collection provides a broad foundation for distinguishing organisms according to their biochemical characteristics. The system is also reported to encompass more than 2,000 microbial phenotypes, reflecting the diversity of observable biological characteristics that can occur among clinically important microorganisms.
Phenotypic recognition is significant because bacterial identification is not based on a single biochemical reaction. Instead, multiple characteristics are evaluated collectively to generate a distinctive analytical pattern. The system therefore interprets a combination of reactions rather than relying on an isolated test result. This multidimensional approach strengthens discrimination among organisms with closely related biochemical properties and supports the generation of a more comprehensive microbial identification profile.
3. New-generation identification and AST cards
Another important feature is the use of specialized identification and antimicrobial susceptibility testing cards. These cards contain miniaturized biochemical substrates or antimicrobial concentrations arranged in a standardized format. The use of miniaturized test systems permits several analytical reactions to be performed simultaneously while reducing the amount of reagent and specimen required for testing.
Identification cards provide the biochemical information required for organism characterization, whereas AST cards are designed to assess bacterial growth responses to antimicrobial agents. By incorporating these functions into standardized cards, the system creates a consistent testing pathway from inoculum preparation through automated analysis. The cards consequently serve as an important interface between the biological specimen and the instrument’s optical and computerized analytical systems.
4. Advanced AST and MIC analysis
The VITEK 2 Compact system provides quantitative information associated with minimum inhibitory concentrations (MICs), which represent the lowest concentrations of an antimicrobial agent capable of inhibiting detectable bacterial growth under defined test conditions. Its knowledge base has been described as containing more than 20,000 MIC distributions covering different antimicrobial agents. This extensive collection contributes to the interpretation of susceptibility patterns and supports the recognition of clinically relevant variations in antimicrobial response.
The system generally provides a range of approximately five to seven MIC doubling dilutions per antimicrobial agent, depending on the test configuration. An extended MIC range can also assist in detecting relatively low-level changes in antimicrobial susceptibility that might otherwise be less readily distinguished. Such information is particularly valuable when organisms exhibit reduced susceptibility or when emerging resistance requires closer examination.
5. Detection of antimicrobial resistance
Detection and characterization of antimicrobial resistance represent another significant capability of the VITEK 2 Compact system. The platform has been described as capable of detecting more than 100 resistance mechanisms in microbial pathogens. Rather than simply reporting whether an organism is susceptible or resistant, automated analysis can identify patterns of phenotypic behaviour associated with particular resistance mechanisms.
This capacity contributes to what may be described as a microbial resistance “fingerprint,” in which the combination of susceptibility responses provides a characteristic profile of the isolate. Recognition of such patterns can alert laboratory personnel to potentially important resistance phenotypes and provide information that is relevant to antimicrobial stewardship and infection-control activities. Nevertheless, resistance interpretations remain dependent on validated criteria, current breakpoints, organism identification, and appropriate laboratory quality-control procedures.
6. User-friendly computerized software and result interpretation
The VITEK 2 Compact system incorporates Windows-based computerized software designed to facilitate instrument operation, data processing, result interpretation, and reporting. Computer-assisted analysis reduces the need for extensive manual calculation and visual interpretation of individual biochemical reactions. Results generated during testing can be processed systematically, allowing the laboratory to obtain an integrated identification and susceptibility profile.
The software also supports the interpretation of antimicrobial results in accordance with applicable laboratory standards and clinical requirements. The information generated by the system can assist laboratory professionals and physicians in selecting appropriate antimicrobial therapy, while recognizing that final prescribing decisions must incorporate the patient’s clinical condition, infection site, pharmacological considerations, and current susceptibility guidelines.
7. Speed, automation, and result verification
Automation is central to the operational design of the VITEK 2 Compact. The system performs sequential analytical activities with limited manual intervention and monitors test reactions during the testing process. Its automated workflow can shorten the time required for identification and AST compared with procedures that depend heavily on manual observation.
An additional feature is the systematic checking of generated results. Automated evaluation allows reaction patterns and susceptibility data to be assessed through programmed analytical rules, helping to identify results that may require additional attention. The resulting combination of rapid processing, automated analysis, and systematic verification can contribute to greater consistency in routine laboratory operations.
8. Integrated instrument components
The physical configuration of the VITEK 2 Compact consists of several interconnected components that facilitate card handling, incubation, reading, loading, and waste management. These include the reader/incubator, waste collection bin, cassette load/unload station, fill door, front user access door, top user access door, filler station, loading/load door, and waste collection door (Figure 1). Each component contributes to a defined stage of the analytical workflow, from preparation and loading of test cards to automated processing and disposal of used materials.
Collectively, these features demonstrate that the VITEK 2 Compact is not simply an identification instrument but an integrated microbiological testing platform. Its combination of extensive reference databases, phenotypic recognition, automated identification, MIC-based AST, resistance-pattern detection, computerized interpretation, and coordinated hardware components provides a structured technological framework for routine bacterial identification and antimicrobial susceptibility testing in clinical microbiology laboratories.
VITEK 2 colorimetric identification card
The VITEK 2 colorimetric identification card is a specialized disposable analytical device designed for the automated identification of bacterial isolates recovered from clinical specimens and for supporting AST. It forms an essential component of the VITEK 2 automated system by providing a standardized platform through which bacterial biochemical characteristics can be examined systematically. Clinical specimens such as blood, urine, and saliva may yield bacterial isolates requiring laboratory characterization before appropriate antimicrobial therapy can be selected. Following isolation and preparation of the organism, the identification card facilitates rapid processing through a series of miniaturized biochemical reactions.
Each VITEK 2 identification card contains multiple reaction wells incorporating substrates that assess distinctive metabolic and biochemical properties of microorganisms (Figure 2). A standardized bacterial suspension is introduced into the card, after which the card is automatically handled by the instrument for incubation and monitoring. As bacterial metabolic activities occur, measurable changes in the reaction wells develop. The system detects these changes through optical, particularly colorimetric, analysis and generates a biochemical profile corresponding to the tested isolate. This profile is subsequently analyzed electronically against the system’s identification database to establish the organism’s identity.
An important operational feature of the VITEK 2 system is the use of individual disposable cards for individual bacterial isolates. This arrangement promotes standardized testing and reduces the need to repeatedly prepare conventional biochemical test media for each organism. Multiple cards can be loaded onto a cassette, allowing numerous isolates to be processed within the same analytical cycle. The capacity to accommodate a series of cards makes the system particularly useful for laboratories processing substantial numbers of clinical isolates, as several organisms can be examined concurrently rather than sequentially.
The VITEK 2 card therefore represents more than a simple identification plate; it is an integrated analytical interface between the bacterial isolate and the automated detection system. By combining miniaturized biochemical testing, optical detection, computerized interpretation, and standardized card-based processing, it contributes to efficient microbial identification and provides a foundation for subsequent susceptibility assessment and clinically relevant laboratory reporting.
Benefits of the VITEK 2 automated compact system
The VITEK 2 Automated Compact System provides several operational and analytical benefits that can strengthen the efficiency of clinical microbiology laboratories. Its principal advantage is the integration of microbial identification and AST within an automated workflow, allowing laboratories to process bacterial and yeast isolates with reduced dependence on prolonged manual procedures. By shortening the interval between inoculation, analysis, and reporting, the system can support the timely generation of microbiological information required for appropriate clinical decision-making.
One important benefit is improved laboratory workflow. Conventional culture-based identification and susceptibility procedures may involve repeated subculturing, biochemical testing, manual observation, and sequential interpretation. These activities can increase hands-on time and introduce opportunities for procedural delay. The VITEK 2 Compact system automates several stages of the analytical process, enabling laboratory personnel to devote less time to repetitive testing activities and more attention to specimen quality, result verification, interpretation, and other essential laboratory responsibilities.
The system also facilitates faster reporting of microbiological results. Timely identification of the causative organism can allow clinicians to reassess empirical antimicrobial therapy earlier, while susceptibility results can provide additional evidence for selecting or modifying treatment. This accelerated turnaround is particularly valuable in situations where delayed recognition of an ineffective antimicrobial regimen may adversely affect patient management. Importantly, automation does not replace professional interpretation; rather, it provides laboratory personnel with structured analytical information that can be reviewed before clinical reporting.
Another significant advantage is the reduction in time required for bacterial and yeast identification. The system uses dedicated identification cards and automated biochemical analysis to generate organism-specific reaction profiles. Computerized interpretation of these profiles can streamline the identification process compared with workflows requiring multiple manually performed biochemical reactions. Similarly, dedicated AST cards facilitate the evaluation of antimicrobial responses and can reduce the time required to obtain susceptibility information.
The VITEK 2 Compact system further offers an extensive identification and susceptibility testing menu, allowing laboratories to accommodate a broad range of clinically relevant microorganisms and antimicrobial agents. Such breadth can be advantageous in laboratories serving diverse patient populations and managing specimens associated with different types of bacterial or yeast infections.
A further benefit is reduced material consumption and laboratory waste. The system employs miniaturized cards, approximately 10 cm × 6 cm × 0.5 cm and weighing about 16 g, which contain multiple testing reactions within a compact format. Miniaturization reduces the physical volume of consumable materials required for individual analyses while supporting multiple reactions within a single card.
The compact and compartmentalized configuration of the VITEK 2 system makes it adaptable to laboratories with different operational capacities. Its relatively small footprint can be advantageous where bench space is limited, while its automated architecture can support laboratories processing larger testing volumes. The system provides a scalable approach to microbiological testing, combining space efficiency, reduced hands-on activity, broad analytical capability, and faster access to identification and AST results.
References
Nakasone, I., Kinjo, T., Yamane, N., Kisanuki, K., & Shiohira, C. M. (2007). Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing. Diagnostic Microbiology and Infectious Disease, 58(2), 191–198.
Joyanes, P., del Carmen Conejo, M., Martínez-Martínez, L., & Perea, E. J. (2001). Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. Journal of Clinical Microbiology, 39(9), 3247–3253.
Barenfanger, J., Drake, C., & Kacich, G. (1999). Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. Journal of Clinical Microbiology, 37(5), 1415–1418.
Doern, G., Vautour, R., Gaudet, M., & Levy, B. (1994). Clinical impact of rapid in vitro susceptibility testing and bacterial identification. Journal of Clinical Microbiology, 32(7), 1757–1762.
Ligozzi, M., Bernini, C., Bonora, M. G., de Fatima, M., Zuliani, J., & Fontana, R. (2002). Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. Journal of Clinical Microbiology, 40(5), 1681–1686.
Ling, T. K., Liu, Z. K., & Cheng, A. F. (2003). Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. Journal of Clinical Microbiology, 41(10), 4705–4707.
Hansen, D. S., Jensen, A. G., Nørskov-Lauritsen, N., Skov, R., & Bruun, B. (2002). Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA). Clinical Microbiology and Infection, 38–44.
Graf, B., Adam, T., Zill, E., & Göbel, U. B. (2000). Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms. Journal of Clinical Microbiology, 38(5), 1782–1785.
bioMérieux. (n.d.). VITEK 2 COMPACT automated microbial identification.
Discover more from Microbiology Class
Subscribe to get the latest posts sent to your email.
